+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Neurological Biomarkers Market by Biomarker Type, Technology Platform, Application, End User - Global Forecast to 2030- Product Image
Neurological Biomarkers Market by Biomarker Type, Technology Platform, Application, End User - Global Forecast to 2030- Product Image
Sale

Neurological Biomarkers Market by Biomarker Type, Technology Platform, Application, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 194 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5454976
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The neurological biomarkers market is witnessing a surge in innovation and adoption as organizations across healthcare and life sciences intensify efforts around precision diagnostics, monitoring, and therapy optimization. As scientific advancements converge with rising global healthcare priorities, leadership teams in diagnostics, R&D, and strategy must assess how developing biomarker solutions can shape their competitive trajectory.

Market Snapshot: Neurological Biomarkers Market

The Neurological Biomarkers Market grew from USD 10.24 billion in 2024 to USD 11.74 billion in 2025. It is expected to continue growing at a CAGR of 14.09%, reaching USD 22.59 billion by 2030. This strong performance underscores the sector’s strategic relevance as stakeholders focus on earlier detection, targeted patient stratification, and more personalized approaches to therapeutic monitoring. Ongoing investment across molecular biology, imaging technologies, and bioinformatics supports both rapid technology adoption and portfolio expansion amid evolving regulatory and payer frameworks.

Scope & Segmentation of the Neurological Biomarkers Market

This report delivers comprehensive coverage of the neurological biomarkers market, enabling senior decision-makers to navigate segment complexities and regional opportunities. Key coverage includes:

  • Biomarker Types: Cellular, Genetic, Imaging, Metabolite, Protein
  • Technology Platforms: Enzyme-Linked Immunosorbent Assay, Imaging Techniques (Computed Tomography, Functional Near-Infrared Spectroscopy, Magnetic Resonance Imaging, Positron Emission Tomography), Mass Spectrometry, Next-Generation Sequencing (RNA Sequencing, Targeted Resequencing, Whole Genome Sequencing), Polymerase Chain Reaction
  • Applications: Diagnostics, Drug Development, Monitoring, Prognostics, Research
  • End Users: Contract Research Organizations, Diagnostic Laboratories, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Research Institutes
  • Geographies Covered: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, Italy, Spain, UAE, Saudi Arabia, South Africa, and others), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Key Companies Analyzed: Danaher Corporation, Thermo Fisher Scientific Inc., Roche Holding AG, Siemens Healthineers AG, Abbott Laboratories, Bio-Rad Laboratories, Inc., PerkinElmer, Inc., Quanterix Corporation, Meso Scale Diagnostics, LLC, Fujirebio Diagnostics, Inc.

Key Takeaways for Senior Decision-Makers

  • Advances in digital analytics, multiomics, and immunoassay sensitivity are enhancing the identification and validation of neurological biomarkers, offering new avenues for personalized medicine.
  • Minimal invasive technologies—such as liquid biopsy, real-time neuroimaging analytics, and AI-powered pattern recognition—are catalyzing adoption across clinical settings.
  • Leading companies are diversifying portfolios through strategic acquisitions, joint ventures, and by embedding artificial intelligence for faster biomarker data interpretation.
  • Hospitals, CROs, diagnostic laboratories, and pharma companies each play pivotal roles in biomarker value chains, adapting to shifting requirements in diagnostics, R&D, and patient management.
  • Regional growth varies: The Americas drive innovation with robust infrastructures and reimbursement models; Asia-Pacific is rapidly scaling production and partnerships; EMEA markets are balancing regulatory rigor with increased public health investment.

Tariff Impact on the Supply Chain

Recent U.S. tariffs implemented in 2025 are raising costs for key raw materials, assay kits, and instrumentation, creating complex supply chain risks for neurological biomarker manufacturers and service providers. Organizations are responding by seeking local production, renegotiating supplier contracts, and exploring new materials. These changes foster supply chain resilience and influence strategic planning, but also introduce longer-term pricing volatility amid geopolitical shifts. Regulatory flexibility around local alternatives further supports efforts to minimize disruption and maintain innovation momentum.

Methodology & Data Sources

This analysis draws on a thorough review of scientific publications, patent landscapes, company filings, regulatory and healthcare policy data, and healthcare expenditure trends. Expert interviews with leaders in science, clinical practice, and industry provide qualitative perspectives, while structured market modeling ensures rigorous quantitative validation. Analytical tools such as SWOT analysis and value chain mapping deepen insights into partnership, competition, and growth strategy.

Why This Report Matters

  • Enables executive teams to identify and prioritize high-growth biomarker segments for targeted investment and portfolio alignment.
  • Provides region-specific intelligence and value chain insights that support faster, evidence-based decisions in sourcing, R&D, and regulatory compliance.

Conclusion

The neurological biomarkers market is evolving rapidly, defined by technology innovation, segment diversity, and shifting regulatory drivers. Stakeholders equipped with strategic insight from this report will be positioned to harness emerging opportunities and mitigate evolving risks in this dynamic clinical landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Neurological Biomarkers Market, by Biomarker Type
8.1. Introduction
8.2. Cellular
8.3. Genetic
8.4. Imaging
8.5. Metabolite
8.6. Protein
9. Neurological Biomarkers Market, by Technology Platform
9.1. Introduction
9.2. Enzyme-Linked Immunosorbent Assay
9.3. Imaging Techniques
9.3.1. Computed Tomography
9.3.2. Functional Near-Infrared Spectroscopy
9.3.3. Magnetic Resonance Imaging
9.3.4. Positron Emission Tomography
9.4. Mass Spectrometry
9.5. Next-Generation Sequencing
9.5.1. RNA Sequencing
9.5.2. Targeted Resequencing
9.5.3. Whole Genome Sequencing
9.6. Polymerase Chain Reaction
10. Neurological Biomarkers Market, by Application
10.1. Introduction
10.2. Diagnostics
10.3. Drug Development
10.4. Monitoring
10.5. Prognostics
10.6. Research
11. Neurological Biomarkers Market, by End User
11.1. Introduction
11.2. Contract Research Organizations
11.3. Diagnostic Laboratories
11.4. Hospitals & Clinics
11.5. Pharmaceutical & Biotechnology Companies
11.6. Research Institutes
12. Americas Neurological Biomarkers Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Neurological Biomarkers Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Neurological Biomarkers Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Danaher Corporation
15.3.2. Thermo Fisher Scientific Inc.
15.3.3. Roche Holding AG
15.3.4. Siemens Healthineers AG
15.3.5. Abbott Laboratories
15.3.6. Bio-Rad Laboratories, Inc.
15.3.7. PerkinElmer, Inc.
15.3.8. Quanterix Corporation
15.3.9. Meso Scale Diagnostics, LLC
15.3.10. Fujirebio Diagnostics, Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. NEUROLOGICAL BIOMARKERS MARKET MULTI-CURRENCY
FIGURE 2. NEUROLOGICAL BIOMARKERS MARKET MULTI-LANGUAGE
FIGURE 3. NEUROLOGICAL BIOMARKERS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2024 VS 2030 (%)
FIGURE 10. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS NEUROLOGICAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS NEUROLOGICAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES NEUROLOGICAL BIOMARKERS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES NEUROLOGICAL BIOMARKERS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC NEUROLOGICAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC NEUROLOGICAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. NEUROLOGICAL BIOMARKERS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. NEUROLOGICAL BIOMARKERS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. NEUROLOGICAL BIOMARKERS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY CELLULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY GENETIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY METABOLITE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY PROTEIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY FUNCTIONAL NEAR-INFRARED SPECTROSCOPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY RNA SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TARGETED RESEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY PROGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS NEUROLOGICAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES NEUROLOGICAL BIOMARKERS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 53. CANADA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 54. CANADA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 55. CANADA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 56. CANADA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 57. CANADA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. CANADA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 59. MEXICO NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 60. MEXICO NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 61. MEXICO NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 62. MEXICO NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 63. MEXICO NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. MEXICO NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 71. ARGENTINA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 72. ARGENTINA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 73. ARGENTINA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 84. UNITED KINGDOM NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 85. UNITED KINGDOM NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 86. UNITED KINGDOM NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 87. UNITED KINGDOM NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 88. UNITED KINGDOM NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. UNITED KINGDOM NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. GERMANY NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 91. GERMANY NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 92. GERMANY NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 93. GERMANY NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 94. GERMANY NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. GERMANY NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 96. FRANCE NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 97. FRANCE NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 98. FRANCE NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 99. FRANCE NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 100. FRANCE NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. FRANCE NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 102. RUSSIA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 103. RUSSIA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 104. RUSSIA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 105. RUSSIA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 106. RUSSIA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. RUSSIA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 108. ITALY NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 109. ITALY NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 110. ITALY NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 111. ITALY NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 112. ITALY NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. ITALY NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 114. SPAIN NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 115. SPAIN NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 116. SPAIN NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 117. SPAIN NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 118. SPAIN NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. SPAIN NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 120. UNITED ARAB EMIRATES NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 121. UNITED ARAB EMIRATES NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 122. UNITED ARAB EMIRATES NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 123. UNITED ARAB EMIRATES NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 124. UNITED ARAB EMIRATES NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. UNITED ARAB EMIRATES NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. SAUDI ARABIA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 127. SAUDI ARABIA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 128. SAUDI ARABIA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 129. SAUDI ARABIA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 130. SAUDI ARABIA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. SAUDI ARABIA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. SOUTH AFRICA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 133. SOUTH AFRICA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 134. SOUTH AFRICA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 135. SOUTH AFRICA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 136. SOUTH AFRICA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. SOUTH AFRICA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 138. DENMARK NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 139. DENMARK NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 140. DENMARK NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 141. DENMARK NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 142. DENMARK NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. DENMARK NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 144. NETHERLANDS NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 145. NETHERLANDS NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 146. NETHERLANDS NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 147. NETHERLANDS NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 148. NETHERLANDS NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. NETHERLANDS NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 150. QATAR NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 151. QATAR NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 152. QATAR NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 153. QATAR NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 154. QATAR NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 155. QATAR NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 156. FINLAND NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 157. FINLAND NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 158. FINLAND NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 159. FINLAND NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 160. FINLAND NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. FINLAND NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 162. SWEDEN NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 163. SWEDEN NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 164. SWEDEN NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 165. SWEDEN NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 166. SWEDEN NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. SWEDEN NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 168. NIGERIA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 169. NIGERIA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 170. NIGERIA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 171. NIGERIA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 172. NIGERIA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. NIGERIA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 174. EGYPT NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 175. EGYPT NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 176. EGYPT NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 177. EGYPT NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 178. EGYPT NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. EGYPT NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 180. TURKEY NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 181. TURKEY NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 182. TURKEY NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 183. TURKEY NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 184. TURKEY NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. TURKEY NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 186. ISRAEL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 187. ISRAEL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 188. ISRAEL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 189. ISRAEL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 190. ISRAEL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 191. ISRAEL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 192. NORWAY NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 193. NORWAY NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 194. NORWAY NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 195. NORWAY NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 196. NORWAY NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 197. NORWAY NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 198. POLAND NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 199. POLAND NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 200. POLAND NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 201. POLAND NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 202. POLAND NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 203. POLAND NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 204. SWITZERLAND NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 205. SWITZERLAND NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 206. SWITZERLAND NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 207. SWITZERLAND NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 208. SWITZERLAND NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 209. SWITZERLAND NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 210. ASIA-PACIFIC NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 211. ASIA-PACIFIC NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 212. ASIA-PACIFIC NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 213. ASIA-PACIFIC NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 214. ASIA-PACIFIC NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 215. ASIA-PACIFIC NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 216. ASIA-PACIFIC NEUROLOGICAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 217. CHINA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 218. CHINA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 219. CHINA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 220. CHINA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 221. CHINA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 222. CHINA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 223. INDIA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 224. INDIA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 225. INDIA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 226. INDIA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 227. INDIA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 228. INDIA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 229. JAPAN NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 230. JAPAN NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 231. JAPAN NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 232. JAPAN NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 233. JAPAN NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 234. JAPAN NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 235. AUSTRALIA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 236. AUSTRALIA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 237. AUSTRALIA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 238. AUSTRALIA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 239. AUSTRALIA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 240. AUSTRALIA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 241. SOUTH KOREA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 242. SOUTH KOREA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 243. SOUTH KOREA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 244. SOUTH KOREA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 245. SOUTH KOREA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 246. SOUTH KOREA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 247. INDONESIA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 248. INDONESIA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 249. INDONESIA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 250. INDONESIA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 251. INDONESIA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 252. INDONESIA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 253. THAILAND NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 254. THAILAND NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 255. THAILAND NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 256. THAILAND NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 257. THAILAND NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 258. THAILAND NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 259. PHILIPPINES NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 260. PHILIPPINES NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 261. PHILIPPINES NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 262. PHILIPPINES NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 263. PHILIPPINES NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 264. PHILIPPINES NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 265. MALAYSIA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 266. MALAYSIA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 267. MALAYSIA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 268. MALAYSIA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 269. MALAYSIA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 270. MALAYSIA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 271. SINGAPORE NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 272. SINGAPORE NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 273. SINGAPORE NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 274. SINGAPORE NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 275. SINGAPORE NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 276. SINGAPORE NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 277. VIETNAM NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 278. VIETNAM NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 279. VIETNAM NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 280. VIETNAM NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 281. VIETNAM NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 282. VIETNAM NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 283. TAIWAN NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 284. TAIWAN NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 285. TAIWAN NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 286. TAIWAN NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 287. TAIWAN NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 288. TAIWAN NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 289. NEUROLOGICAL BIOMARKERS MARKET SHARE, BY KEY PLAYER, 2024
TABLE 290. NEUROLOGICAL BIOMARKERS MARKET, FPNV POSITIONING MATRIX, 2024

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Neurological Biomarkers market report include:
  • Danaher Corporation
  • Thermo Fisher Scientific Inc.
  • Roche Holding AG
  • Siemens Healthineers AG
  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • PerkinElmer, Inc.
  • Quanterix Corporation
  • Meso Scale Diagnostics, LLC
  • Fujirebio Diagnostics, Inc.

Table Information

Report AttributeDetails
No. of Pages194
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 11.74 Billion
Forecasted Market Value ( USD ) by 2030 $ 22.59 Billion
Compound Annual Growth Rate14.0%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Neurological Biomarkers Market Size, Share & Trends Analysis Report by Application (Alzheimer's, Parkinson's, Multiple Sclerosis, Autism), Type, End Use, Region, with Growth Forecasts, 2025-2030 - Product Image

Neurological Biomarkers Market Size, Share & Trends Analysis Report by Application (Alzheimer's, Parkinson's, Multiple Sclerosis, Autism), Type, End Use, Region, with Growth Forecasts, 2025-2030

  • Report
  • 120 Pages
  • Global
From
Neurological Biomarkers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Neurological Biomarkers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 181 Pages
  • Global
From
Predictive Biomarkers Market Size, Share & Trends Analysis Report by Indication, Technology (Diagnostics, Drug Discovery & Development, Personalized Medicine, Disease Risk Assessment), and Region with Growth Forecasts, 2025-2030 - Product Image

Predictive Biomarkers Market Size, Share & Trends Analysis Report by Indication, Technology (Diagnostics, Drug Discovery & Development, Personalized Medicine, Disease Risk Assessment), and Region with Growth Forecasts, 2025-2030

  • Report
  • 150 Pages
  • Global
From
Neurological Biomarkers for Alzheimer`s and Parkinson`s Diseases - Global Strategic Business Report - Product Image

Neurological Biomarkers for Alzheimer`s and Parkinson`s Diseases - Global Strategic Business Report

  • Report
  • 196 Pages
  • Global
From
Brain Biomarkers Market by Product, Biomarker Type, Technology, Indication, End User - Global Forecast to 2030 - Product Image

Brain Biomarkers Market by Product, Biomarker Type, Technology, Indication, End User - Global Forecast to 2030

  • Report
  • 190 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.